Krystal Biotech, Inc. (KRYS)
NASDAQ: KRYS · Real-Time Price · USD
372.25
+12.32 (3.42%)
At close: Jun 26, 2026, 4:00 PM EDT
368.00
-4.25 (-1.14%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Krystal Biotech Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Krystal Biotech stock have an average target of 342.2, with a low estimate of 284 and a high estimate of 403. The average target predicts a decrease of -8.07% from the current stock price of 372.25.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Krystal Biotech stock from 11 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 11 | 10 | 10 | 10 | 10 | 10 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 11 | 10 | 11 | 11 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| TD Cowen | TD Cowen | Buy Maintains $306 → $403 | Buy | Maintains | $306 → $403 | +8.26% | Jun 18, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Reiterates $310 → $361 | Buy | Reiterates | $310 → $361 | -3.02% | Jun 16, 2026 |
| Bank of America Securities | Bank of America Securities | Buy Maintains $364 | Buy | Maintains | $364 | -2.22% | Jun 1, 2026 |
| William Blair | William Blair | Buy Maintains n/a | Buy | Maintains | n/a | n/a | May 18, 2026 |
| Evercore ISI | Evercore ISI | Buy Maintains $295 → $300 | Buy | Maintains | $295 → $300 | -19.41% | May 5, 2026 |
Financial Forecast
Revenue This Year
525.24M
from 389.13M
Increased by 34.98%
Revenue Next Year
677.61M
from 525.24M
Increased by 29.01%
EPS This Year
8.29
from 6.84
Increased by 21.22%
EPS Next Year
10.08
from 8.29
Increased by 21.53%
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 549.9M | 722.9M | |
| Avg | 525.2M | 677.6M | |
| Low | 494.0M | 641.2M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 41.3% | 37.6% | |
| Avg | 35.0% | 29.0% | |
| Low | 26.9% | 22.1% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.52 | 13.38 | |
| Avg | 8.29 | 10.08 | |
| Low | 6.21 | 6.66 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 112.3% | 61.4% | |
| Avg | 21.2% | 21.5% | |
| Low | -9.2% | -19.7% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.